|
1 Indications And Usage Trelegy Ellipta Is Indicated For The Maintenance Treatment Of Patients With Chronic Obstructive Pulmonary Disease (Copd). Important Limitations Of Use Trelegy Ellipta Is Not Indicated For The Relief Of Acute Bronchospasm Or For The Treatment Of Asthma. Trelegy Ellipta Is A Combination Of Fluticasone Furoate, An Inhaled Corticosteroid (Ics); Umeclidinium, An Anticholinergic; And Vilanterol, A Long‑acting Beta 2 -Adrenergic Agonist (Laba), Indicated For The Maintenance Treatment Of Patients With Chronic Obstructive Pulmonary Disease (Copd). ( 1 ) Important Limitations Of Use: Not Indicated For Relief Of Acute Bronchospasm Or The Treatment Of Asthma. ( 1 , 5.2 )
|